My friends in China have said that the country, ironically enough, is in no rush to vaccinate people against COVID-19, as they say it controlled the virus well across most of China.
That is the same attitude and policy in Taiwan: “We are controlling the situation well, so we are not in a hurry.”
Ponder upon the irony of this situation for a minute.
The New York Times has praised Taiwan for its undeniable success in controlling COVID-19, but cautioned that no country can isolate itself forever. Herd immunity, achieved through widespread infections or vaccinations is the only way to fully control the disease in the long run. You do not have to be a medical professional to realize that.
Taiwan has yet to embark on a large-scale vaccination rollout, and China has the lowest rate of vaccine injections among major countries. Could a reversal of fortunes be in the making?
Taiwan has, with the opposition party’s help, recognized the looming crisis, and is mobilizing its power to address the situation. In contrast, China is sending most of its vaccines to poorer countries as a part of its vaccine diplomacy. Is it a wise move in the long run, considering that China has long and porous borders that are susceptible to foreign COVID-19 invasions?
If another COVID-19 outbreak occurs, China, with its draconian measures, could suppress it again, but how much more suffering must its citizens endure? To what extent should people in more advanced economies concern themselves with this?
It seems that the messenger ribonucleic acid vaccines are to be the most promising and fast-acting tools against potential COVID-19 variants. Will Chinese vaccines based on an old technology using dead viruses meet the challenge? Only a real-world and massive vaccination campaign, such as what Israel is doing, can answer that.
There is not much room for complacency: The victor of this “war” will likely be rewarded by being the last man standing at the end.
People must carefully consider the situation before jumping to any conclusions.
It is time for vaccination, regardless of a country’s status in the fight against COVID-19.
Simon Tang is an adjunct professor at California State University, Fullerton.
From the Iran war and nuclear weapons to tariffs and artificial intelligence, the agenda for this week’s Beijing summit between US President Donald Trump and Chinese President Xi Jinping (習近平) is packed. Xi would almost certainly bring up Taiwan, if only to demonstrate his inflexibility on the matter. However, no one needs to meet with Xi face-to-face to understand his stance. A visit to the National Museum of China in Beijing — in particular, the “Road to Rejuvenation” exhibition, which chronicles the rise and rule of the Chinese Communist Party — might be even more revealing. Xi took the members
The Chinese Nationalist Party (KMT) and the Taiwan People’s Party (TPP) on Friday used their legislative majority to push their version of a special defense budget bill to fund the purchase of US military equipment, with the combined spending capped at NT$780 billion (US$24.78 billion). The bill, which fell short of the Executive Yuan’s NT$1.25 trillion request, was passed by a 59-0 margin with 48 abstentions in the 113-seat legislature. KMT Chairwoman Cheng Li-wun (鄭麗文), who reportedly met with TPP Chairman Huang Kuo-chang (黃國昌) for a private meeting before holding a joint post-vote news conference, was said to have mobilized her
Before the Chinese Communist Party (CCP) and its People’s Liberation Army (PLA) can blockade, invade, and destroy the democracy on Taiwan, the CCP seeks to make the world an accomplice to Taiwan’s subjugation by harassing any government that confers any degree of marginal recognition, or defies the CCP’s “One China Principle” diktat that there is no free nation of Taiwan. For United States President Donald Trump’s upcoming May 14, 2026 visit to China, the CCP’s top wish has nothing to do with Trump’s ongoing dismantling of the CCP’s Axis of Evil. The CCP’s first demand is for Trump to cease US
As artificial intelligence (AI) becomes increasingly widespread in workplaces, some people stand to benefit from the technology while others face lower wages and fewer job opportunities. However, from a longer-term perspective, as AI is applied more extensively to business operations, the personnel issue is not just about changes in job opportunities, but also about a structural mismatch between skills and demand. This is precisely the most pressing issue in the current labor market. Tai Wei-chun (戴偉峻), director-general of the Institute of Artificial Intelligence Innovation at the Institute for Information Industry, said in a recent interview with the Chinese-language Liberty Times